Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxol + Xeloda vs Taxotere + Xeloda in Metastatic Breast Cancer
NCT00201435Phase 3Completed
- Sponsor
- Norwegian Breast Cancer Group
- Start
- Mar 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, docetaxel in breast cancer, sponsored by Norwegian Breast Cancer Group. Started Mar 2005; status: completed.
02
Drugs
paclitaxeldocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00201435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201435.